One governed study state.
Tenvia Clinical
Built from the problems clinical teams live with every day.
Tenvia is a founder led clinical technology company building a governed intelligence and orchestration layer around the study rather than another disconnected point solution.
Start with one controlled problem. Produce an inspectable result. Expand only when the value is clear.
Why Tenvia
The study should not be reconstructed at every handoff.
Clinical development still relies on people repeatedly interpreting the same study across documents, functions, CROs, vendors and specialist systems. Tenvia is being built to preserve the intent, evidence and authority behind the work.
Evidence connected to decisions.
Requirements connected to approved intent.
Execution connected back to the plan.
Founder perspective
Enterprise technology experience, applied to clinical development.
Rameez Zaman has spent 15 years working across enterprise technology and clinical technology, including IBM and Medidata. Tenvia is shaped by direct experience of the commercial and operational friction created when study teams, providers and systems work from different interpretations of the trial.
Sponsor and CRO operating realities.
Enterprise buying and diligence expectations.
Clinical technology fragmentation.
The need for ambitious claims to remain supportable.
Operating principles
Build trust into the product, not around the marketing.
Tenvia is being developed around evidence, explicit authority, progressive adoption and honest release boundaries.
No autonomous clinical decision making.
No requirement for every partner to adopt at once.
No claim that a foundation model is the product.
No compliance or connector claim without evidence.
Tenvia is preparing controlled design partnerships. Production scope, contracting entity details and assurance evidence are confirmed before a paid pilot or production engagement.
Speak with the founder
Bring the clinical problem that should not still require this much manual coordination.
The first conversation is about the work, the evidence and the operating boundary. It is not a generic software demonstration.
No confidential study information is required for an introductory discussion.